Abstract
By dissolving drug molecules in these solutions, a unit dosage form for oral administration can be generated for oral administration. Self-emulsifying drug delivery system (SEDDS) is utilized to address the inadequate bioavailability of poorly soluble and highly permeable drugs, according to the literature. These methods can disseminate and deliver hydrophobic medications as a unit dose form for oral administration in this fashion. SEDDS formulations self-emulsify (micro/nano) after being discharged into the intestinal lumen and coming into contact with the gastrointestinal (GI) fluid. Several factors must be considered to make the oral drug administration difficult, including poor water solubility and limited permeability. Self-emulsifying drug delivery can increase the solubility of biopharmaceutical classification system (BCS) II medicines. The SEDDS is a drug delivery system that enhances the solubility of lipophilic medications. It has risen in popularity over time. Under moderate agitation and subsequent dilution, GI fluids are categorized as hydrophilic liquid mixes that are isotropic. This research looks at a variety of uses as well as recent advancements in SEDDS composition, evaluation, dosage forms, and novel techniques to convert liquid SEDDS to solids. Final Thoughts Determining whether or not it is feasible to construct a BCS Category 2 medication formulation based on SEDDS represents a significant contribution of this effort. Medicines with solubility issues and low and variable bioavailability will benefit from the connected technologies.
Highlights
Self-emulsifying drug delivery system (SEDDS) is utilized to address inadequate bioavailability of poorly soluble and highly permeable drugs, according to the literature
A drug delivery system’s (DDS) lipid makeup determines whether the drug will be released immediately or later
Self‐emulsifying drug delivery systems Nano sizing by precipitation Cryogenic and super critical fluid technologies Melt‐granulation Melt‐extrusion
Summary
Self-emulsifying drug delivery system (SEDDS) is utilized to address inadequate bioavailability of poorly soluble and highly permeable drugs, according to the literature These methods can disseminate and deliver hydrophobic medications as a unit dose form for oral administration in this fashion. “Soluble-limited absorbable dosages” refers to Class II drugs that have been shown to have an equilibrium between their permeability and solubility, according to this theory When it comes to valuation (Fig. 1) [8,9,10]. If you’re curious about drug solubility, some options available to the pharmaceutical industry may be employed to improve the solubility of BCS Class II medicines To categorize these tactics, we can use the following methods: In the case of Table 1 [11,12,13].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
